Euro area vs Mauritania: Access to anti-retroviral drugs, male
Euro area
87.0%
in 2022
Mauritania
97.0%
in 2024
Euro area rank
1st
Mauritania rank
2nd
Access to anti-retroviral drugs, male over time
- Euro area
- Mauritania
How they compare
Mauritania currently reports 97.0% against 87.0% in Euro area, a difference of 10.0%.
That makes Mauritania's figure about 1.1 times Euro area's.
Across all 23 years both countries report, Euro area has been ahead every year.
Euro area ranks 1st and Mauritania ranks 2nd of 19 groups.
Euro area has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Euro area | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.7% | 3.7% | 47.0% | Euro area |
| 2010s | 75.2% | 33.4% | 41.8% | Euro area |
| 2020s | 86.1% | 70.3% | 15.7% | Euro area |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Euro area or Mauritania?
- Mauritania, at 97.0% against 87.0% in Euro area as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Euro area and Mauritania?
- 10.0%, with Mauritania ahead.
- How many years of comparable data are there for Euro area and Mauritania?
- 23 years are reported by both, from 2000 to 2022.
- How do Euro area and Mauritania rank globally for access to anti-retroviral drugs, male?
- Euro area ranks 1st and Mauritania ranks 2nd of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.